Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:
- an article explaining how “St Jude Medical will have to defend claims that its catheters infringe[d] a company’s revived patent”;
- an article discussing how the Federal Circuit “affirm[ed] — on a procedural technicality — a precedential decision of a Precedential Opinion Panel (POP) of the Patent Trial and Appeal Board (PTAB) that granted a motion to amend claims in an inter partes review (IPR) proceeding”; and
- yet another article assessing how “Daiichi Sankyo Co. Ltd.‘s best hope for escaping a $42 million patent infringement verdict won by Seagen Inc. may lie in its separate administrative challenge to Seagen’s patent.”